TR201004720T1 - Majör depresif bozukluğun tedavisi için o-desmetil venlafaksin - Google Patents
Majör depresif bozukluğun tedavisi için o-desmetil venlafaksinInfo
- Publication number
- TR201004720T1 TR201004720T1 TR2010/04720T TR201004720T TR201004720T1 TR 201004720 T1 TR201004720 T1 TR 201004720T1 TR 2010/04720 T TR2010/04720 T TR 2010/04720T TR 201004720 T TR201004720 T TR 201004720T TR 201004720 T1 TR201004720 T1 TR 201004720T1
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- depressive disorder
- major depressive
- desmethyl venlafaxine
- odv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides methods for treafing MDD. in general, the methods comprise administering to a pafient in need thereof a daily dose of about 50 mg ODV or an equivalent amount of a pharmaceutically acceptable salt thereof. in certain embodiments, a patient in need of treatment is characterized by a primary diagnosis of MDD. in some embodiments, the dose is administered as a single daily dose. in one set of embodiments, the methods involve administering an oral dosage form comprising the succinate salt of ODV.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2007/086986 WO2009075677A1 (en) | 2007-12-10 | 2007-12-10 | O-desmethyl-venlafaxine for treating major depressive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201004720T1 true TR201004720T1 (tr) | 2010-11-22 |
Family
ID=39326191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/04720T TR201004720T1 (tr) | 2007-12-10 | 2007-12-10 | Majör depresif bozukluğun tedavisi için o-desmetil venlafaksin |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110027324A1 (tr) |
| AU (1) | AU2007362336A1 (tr) |
| BR (1) | BRPI0722303A2 (tr) |
| CA (1) | CA2708832A1 (tr) |
| MX (1) | MX2010006310A (tr) |
| TR (1) | TR201004720T1 (tr) |
| WO (1) | WO2009075677A1 (tr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012024576A2 (pt) | 2010-03-31 | 2016-05-31 | Wockhardt Ltd | composição farmacêutica de liberação modificada compreendendo desvenlafaxina ou sais da mesma e processo para preparação da dita composição |
| AU2011251747B2 (en) * | 2010-05-14 | 2014-08-07 | Alembic Limited | Extended release formulations of desvenlafaxine base |
| US20200000229A1 (en) * | 2018-06-28 | 2020-01-02 | Summit Product Development, LLC | Low Profile Cabinet Organizer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007005961A2 (en) * | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| TW200740427A (en) * | 2005-07-15 | 2007-11-01 | Wyeth Corp | Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate |
-
2007
- 2007-12-10 TR TR2010/04720T patent/TR201004720T1/tr unknown
- 2007-12-10 AU AU2007362336A patent/AU2007362336A1/en not_active Abandoned
- 2007-12-10 US US12/747,096 patent/US20110027324A1/en not_active Abandoned
- 2007-12-10 MX MX2010006310A patent/MX2010006310A/es not_active Application Discontinuation
- 2007-12-10 WO PCT/US2007/086986 patent/WO2009075677A1/en active Application Filing
- 2007-12-10 CA CA2708832A patent/CA2708832A1/en not_active Abandoned
- 2007-12-10 BR BRPI0722303-0A patent/BRPI0722303A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009075677A1 (en) | 2009-06-18 |
| BRPI0722303A2 (pt) | 2014-04-22 |
| AU2007362336A1 (en) | 2009-06-18 |
| CA2708832A1 (en) | 2009-06-18 |
| US20110027324A1 (en) | 2011-02-03 |
| MX2010006310A (es) | 2010-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201690069A1 (ru) | Применение высоких доз придопидина для лечения болезни хантингтона | |
| NZ593065A (en) | Dosage regimen for a s1p receptor agonist | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| EA201390332A1 (ru) | Дейтерированные аналоги придопидина, применимые в качестве допаминергических стабилизаторов | |
| CO6361928A2 (es) | Modulares de aril metil benzoquinazolinona alostericos positivos del receptor m1 | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| IL189546A0 (en) | Therapy for the treatment of disease | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
| BR112014015482A8 (pt) | compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| IL196425A (en) | Dosage unit for oral administration containing ibuprofen and pamotidine | |
| JP2013541583A5 (tr) | ||
| RU2019111096A (ru) | Лекарственные формы леводопы для быстрого купирования болезни паркинсона | |
| BR112013018598A2 (pt) | composição farmacêutica, método para tratar uma doença cardíaca, uso de (s)-metil-3-[4-(2-hidroxi-3-[4-(2-hidroxi-3-isopropilamino) propoxi] fenilpropionato, e, método para controlar frequência cardíaca | |
| TR201004720T1 (tr) | Majör depresif bozukluğun tedavisi için o-desmetil venlafaksin | |
| MY160914A (en) | Novel compound and medical use thereof | |
| BR112012011316A2 (pt) | tivozanib e temsirolimus em combinação | |
| JP7312286B2 (ja) | うつ病を予防または治療するための安息香酸またはその塩および誘導体 | |
| RU2012114097A (ru) | Терапевтический агент против хронической боли | |
| JP6216913B1 (ja) | 医薬組成物 | |
| RU2008107113A (ru) | Средство и способ профилактики и лечения пациентов с болезнью альцгеймера | |
| BR112015028581A2 (pt) | composição farmacêutica de dosagem baixa, utilização do ácido, método para o tratamento da doença inflamatória e composição farmacêutica | |
| RU2014125701A (ru) | Фармацевтическая композиция для профилактики или лечения гипертриглицеридемии или вызванных гипертриглицеридемией заболеваний |